European Legislators Want Stricter Disclosure Laws

08/15/2002 | Financial Times (free content)

The European Agency for the Evaluation of Medicines, which is equivalent to the U.S.' FDA, is planning to ask drug companies to submit data on their products, including those that failed to gain regulatory approval. But the drug industry says the planned disclosure law could mar commercial prospects.

View Full Article in:

Financial Times (free content)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC